COR Cencora
Health Care · Health Care Distributors · close $340.92 (2026-10-16) · latest quarter in EDGAR: 2026-06-30
Cencora (COR) has a ThetaGrade House Rating of 51/100 (grade C), ranking #24 of 150 in Health Care. Its strongest pillars are valuation (83) and growth (52); its weakest is balance sheet (38). TTM revenue growth is 5.1% and operating margin 0.9%.
Data as of .
Analyst sentiment
weight 7.5% · 50| Consensus score (1–5) (3.8%) | derived | 46 |
| 90-day net rating shift (3.8%) | derived | 29 |
Growth
weight 30.83% · 52| Revenue growth YoY (TTM) (12.3%) | 5.1% | 25 |
| EPS growth YoY (TTM) (12.3%) | 38.3% | 73 |
| Revenue acceleration (6.2%) | 1.2% | 64 |
Profitability
weight 18.5% · 43| Operating margin (9.9%) | 0.9% | 26 |
| 4Q gross-margin change (8.6%) | 0.5% | 62 |
Balance sheet
weight 18.5% · 38| Net debt / EBITDA (9.9%) | 2.11× | 42 |
| Current ratio (4.9%) | 0.93 | 9 |
| Interest coverage (3.7%) | 8.53× | 66 |
Cash flow
weight 12.33% · 49| FCF margin (6.2%) | 1.0% | 21 |
| FCF yield (6.2%) | 4.9% | 78 |
Valuation
weight 12.33% · 83| P/E (inverted) (6.2%) | 25.31× | 67 |
| EV/Sales (inverted) (6.2%) | 0.22× | 98 |
Technicals (EOD)
| RSI(14) | 70.0 |
| EMA 9 / 21 | 329.89 / 323.01 |
| 200-day SMA | 317.48 |
| Volume vs 20d avg | 1.54× |
| 20-day return | 10.2% |
Exit-rule monitor
- EXITRating break: House Rating below 60
Data source per metric (SEC XBRL tag or derivation): Revenue: Revenues · Gross profit: GrossProfit · Operating income: OperatingIncomeLoss · Interest expense: InterestPaidNet · D&A: DepreciationDepletionAndAmortization · EPS: EarningsPerShareDiluted · Market cap: SEC shares (dei EntityCommonStockSharesOutstanding (cover page)) × EOD close · P/E: EOD close ÷ SEC TTM EPS (EarningsPerShareDiluted).
Get rating changes like COR's in the free Daily Brief
The market’s key events and signals, digested before the open.
- ✓ Pre-market Daily Brief: events, headlines, rating changes (2-min read)
- ✓ Sunday: Top 5 Weekly Picks, exit alerts, CSP put watchlist
- ✓ OPEX, FOMC, CPI and jobs-day reminders
Free. Want more? See Premium (waitlist).
FAQ
- What is COR's House Rating?
- COR scores 51 out of 100 (grade C) as of 2026-10-16, ranking #24 of 150 Health Care stocks we cover.
- What do analysts say about COR?
- ThetaGrade's analyst-sentiment pillar for COR scores 50/100 against its sector peers, which we read as mixed. This is our own derived score; we do not republish individual analyst ratings, counts or targets.
- When does COR report earnings next?
- COR's next earnings report is estimated for about 2026-11-04 (window 2026-11-01 to 2026-11-07), based on its past SEC 8-K earnings filings. This is an estimate, not a company-confirmed date.
- Is COR a buy?
- ThetaGrade does not give personal advice. The House Rating is an educational, rules-based summary of public data; see the methodology for how it is built.
Sources: SEC EDGAR filings (fetched 2026-10-18), Finnhub recommendation trends, Massive EOD prices. Scores are sector percentiles; a factor without usable data is a data gap: it is left out and the remaining weights are renormalized (nothing is imputed). Educational only. Methodology